Corticotropin-releasing Hormone Induces Fas Ligand Production and Apoptosis in PC12 Cells via Activation of p38 Mitogen-activated Protein Kinase
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Recent experimental findings involve corticotropin-releasing hormone (CRH) in the cellular response to noxious stimuli and possibly apoptosis. The aim of the present work was to examine the effect of CRH on apoptosis and the Fas/Fas ligand system in an in vitro model, the PC12 rat pheochromocytoma cell line, which is widely used in the study of apoptosis and at the same time expresses the CRH/CRH receptor system. We have found the following. CRH induced Fas ligand production and apoptosis. These effects were mediated by the CRH type 1 receptor because its antagonist antalarmin blocked CRH-induced apoptosis and Fas ligand expression. CRH activated p38 mitogen-activated protein kinase, which was found to be essential for CRH-induced apoptosis and Fas ligand production. CRH also promoted a rapid and transient activation of ERK1/2, which, however, was not necessary for either CRH-induced apoptosis or Fas ligand production. Thus, CRH promotes PC12 apoptosis via the CRH type 1 receptor, which induces Fas ligand production via activation of p38.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Brunson, K. L., Eghbal-Ahmadi, M., Bender, R., Chen, Y., & Baram, T. Z. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151224898 · Cited by 236
Cited by
Hillhouse, E. W., & Grammatopoulos, D. K. (2006) · Endocrine Reviews · doi:10.1210/er.2005-0034 · Cited by 353
Grammatopoulos, D. K., & Chrousos, G. P. (2002) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(02)00670-7 · Cited by 277
The Corticotropin-Releasing Factor Family: Physiology of the Stress Response
Deussing, J. M., & Chen, A. (2018) · Physiological Reviews · doi:10.1152/physrev.00042.2017 · Cited by 260
HPA axis responsiveness to stress: implications for healthy aging
Aguilera, G. (2011) · Experimental Gerontology · doi:10.1016/j.exger.2010.08.023 · Cited by 250
“In vitro studies have shown either neuroprotective, or pro-apoptotic effects of CRH, both effects mediated by type-1 receptors (Dermitzaki et al., 2002; Wang et al., 2003; Bayatti et al., 2003; Wang et al., 2004).”
BackgroundNeuroendocrine Mechanisms in Pregnancy and Parturition
Petraglia, F., Imperatore, A., & Challis, J. R. G. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0019 · Cited by 224
Corticotropin releasing factor promotes breast cancer cell motility and invasiveness
Androulidaki, A., Dermitzaki, E., Venihaki, M., Karagianni, E., Rassouli, O., Andreakou, E., Stournaras, C., Margioris, A. N., & Tsatsanis, C. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-30 · Cited by 58
Self-citationMonfrim, X., Gazal, M., De Leon, P. B., Quevedo, L., Souza, L. D., Jansen, K., Oses, J. P., Pinheiro, R. T., Silva, R. A., Lara, D. R., et al. (2014) · Bipolar Disorders · doi:10.1111/bdi.12214 · Cited by 52
CRH inhibits NF-κB signaling in human melanocytes
Zbytek, B., Pfeffer, L. M., & Slominski, A. T. (2006) · Peptides · doi:10.1016/j.peptides.2006.07.017 · Cited by 45
Petsas, G., Jeschke, U., Richter, D. U., Minas, V., Hammer, A., Kalantaridou, S., Toth, B., Tsatsanis, C., Friese, K., & Makrigiannakis, A. (2012) · Molecular Human Reproduction · doi:10.1093/molehr/gas027 · Cited by 29
Self-citation
Metadata
- Authors
- Dermitzaki, E., Tsatsanis, C., Gravanis, A., & Margioris, A. N.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2002-04
- Volume
- 277
- Issue
- 14
- Pages
- 12280-12287
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2040201685
- Cited by
- 90
- References
- 1
- FWCI
- 2.38
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.